ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2021 American Transplant Congress

    Early Portal Vein Ligation in the Setting of Shorter Hepatectomy May Contribute to Better Surgical Outcomes in Deceased Donor Liver Transplantation

    K. Delvecchio, T. Kitajima, A. Mohamed, S. Yeddula, M. Tayseer, T. Ivanics, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai

    Henry Ford Hosptial, Detroit, MI

    *Purpose: Few published reports have suggested lower blood loss in association with early portal vein ligation (e-PVL) during liver transplantation surgery, however there are currently…
  • 2021 American Transplant Congress

    Outcomes of Surgical Resection versus Liver Transplantation in Hilar Cholangiocarcinoma

    M. K. White1, F. Aucejo2, A. Moro2, K. Sasaki2, K. Stephans3, B. Estfan4, C. Quintini2, B. Eghtesad2, K. Hashimoto2, F. Masato2, C. Miller2, K. Menon5

    1Cleveland Clinic, Cleveland, OH, 2General Surgery, Cleveland Clinic, Cleveland, OH, 3Radiation Oncology, Cleveland Clinic, Cleveland, OH, 4Oncology, Cleveland Clinic, Cleveland, OH, 5Gastroenterology & Hepatology, Cleveland Clinic, Cleveland, OH

    *Purpose: To compare the outcomes of patients with hilar cholangiocarcinoma (hCCA) who underwent either surgical resection or liver transplantion (LT).*Methods: All hCCA patients who underwent…
  • 2021 American Transplant Congress

    Role of Recovering Surgeon in DCD Liver Transplant Outcomes

    E. Macdonough, K. Pont, B. Aqel, K. Valenti, W. Hewitt, A. Moss, K. S. Reddy, C. Jadlowiec

    Mayo Clinic, Phoenix, AZ

    *Purpose: Donation after cardiac death (DCD) liver transplant (LT) outcomes have continued to improve. Variability in outcomes has been attributed to center and recovering surgeon…
  • 2021 American Transplant Congress

    Temporal Changes in Renal Function Predict Waitlist Death or Deterioration in Pediatric Liver Transplantation

    N. Thalji, L. Thalji, S. Ibrahim, T. Diwan, P. Kamath, J. Heimbach

    Mayo Clinic Rochester, Minnesota, Rochester, MN

    *Purpose: Renal dysfunction at the time of listing predicts inferior waitlist outcomes in pediatric liver transplant candidates, independent of the Pediatric End-Stage Liver Disease (PELD)…
  • 2020 American Transplant Congress

    Stewardship Effortsto Eliminate Post-Orthotopic Liver Transplant Antibiotics in Uncomplicated Patients Leads to Equivalent Safety Outcomes

    J. Yau, J. Dann, W. Ally, J. Geyston, S. Pelletier, C. Sifri

    University of Virginia Health System, Charlottesville, VA

    *Purpose: The purpose of this study was to evaluate safety and efficacy endpoints of a revised post-operative antibiotic prophylaxis protocol in orthotopic liver transplant (OLT)…
  • 2020 American Transplant Congress

    The Perioperative Coagulation Profile of Hepatocellular Carcinoma During Liver Transplantation Compared to Patients with Non-Malignant Disease: A Cause or Association for Decreased Blood Product Utilization During Liver Transplantation?

    H. B. Moore, E. Pomfret, J. Pomposelli, C. Walker, R. Choudhury, H. Yaffe, M. Wachs, T. Bak, K. Conzen, M. Adams, T. Pshak, T. L. Nydam

    University of Colorado, Aurora, CO

    *Purpose: Hepatobiliary malignancies have been associated with hyper-coagulability. However, the impact of hepatocellular carcinoma (HCC) on coagulation during liver transplantation remains less clear. We hypothesize…
  • 2020 American Transplant Congress

    Evaluation of Pre-Transplant T Cell Exhaustion as a Mechanism for Immune Dysfunction and Recipient Risk of Death Following Liver Transplant

    K. E. Lunsford1, N. Aware2, K. Cleveland3, D. T. Nguyen4, E. A. Graviss4, L. J. Minze3, T. N. Eagar4, X. C. Li3, R. M. Ghobrial3

    1Department of Surgery, Rutgers New Jersey Medical School, Newark, NJ, 2Department of Surgery, Houston Methodist Hosptial, Houston, TX, 3Department of Surgery, Houston Methodist Hospital, Houston, TX, 4Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX

    *Purpose: Cirrhosis-related immune dysfunction likely contributes to early mortality following liver transplant (LT) resulting from infections. We previously identified a pre-transplant biomarker panel for immune…
  • 2020 American Transplant Congress

    Re-Establishing Abstinence after Alcohol Relapse after Early Transplant (LT) for Alcoholic Hepatitis (AH) Provides Survival Advantage

    J. Rice1, B. Lee2, G. Therapondos3, G. Im4, A. Lazar2, M. Lucey1, E. Weinberg5, H. Han6, H. Maddur7, M. Ghobrial8, C. Hsu9, O. Fix10, S. Eswaran11, K. Shetty12, N. Jakhete12, D. Victor8, D. Foley1, N. Mehta2, M. Rinella7, T. Schiano4, C. Mobley8, N. Terrault6

    1U of WI SMPH, Madison, WI, 2UCSF, San Francisco, CA, 3Oschner, New Orleans, LA, 4Mt Sinai, New York, NY, 5U Penn, Philadelphia, PA, 6USC, Los Angeles, CA, 7NW Univ, Chicago, IL, 8Houston Mdt, Houston, TX, 9GTown U, Washington, DC, 10Swed Med, Seattle, WA, 11Rush Med C, Chicago, IL, 12U of MD, Baltimore, MD

    *Purpose: Among the ACCELERATE-AH cohort: (i) Identify factors associated with re-established abstinence in patients with alcohol relapse after LT for alcoholic hepatitis (AH); (ii) Determine…
  • 2020 American Transplant Congress

    Type 1 Innate Lymphoid Cells Are Critical Pro-Inflammatory Effector Cells in a Fatty Liver Mouse Model of Ischemia-Reperfusion Injury

    J. Kang, K. Loh, J. Green, M. Sadat, M. Stovroff, A. Duttargi, B. Kallakury, K. Khan, T. Fishbein, A. Kroemer

    MedStar Georgetown Transplant Institute, Washington, DC

    *Purpose: Innate lymphoid cells (ILCs), the most recently described family of lymphoid cells, play fundamental roles in tissue homeostasis and immune regulation through the activation…
  • 2020 American Transplant Congress

    Long Term Outcomes Following Uncontrolled and Controlled Donation after Cardiac Death Liver Transplantation in the United States

    R. A. Choudhury1, D. Yoeli1, H. Yaffe1, H. B. Moore1, G. Hoeltzel2, A. Schulick1, K. D. Conzen1, J. J. Pomposelli1, E. A. Pomfret1, T. L. Nydam1

    1Department of Surgery- Division of Transplantation Surgery, University of Colorado Hospital, Aurora, CO, 2Thomas Jefferson University Hospital, Philadelphia, PA

    *Purpose: Poor short-term outcomes following uncontrolled donation after cardiac death (uDCD) liver transplantation has led to near non-utilization of such donor allografts in the modern…
  • « Previous Page
  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences